Axsome Therapeutics, Inc. Financials

Market Capitalization $5.00 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-19.57
Forward PE	-47.74
Price to Sales TTM	$14.76
Price to Book MRQ	$53.76
Enterprise to Revenue	14.37
Enterprise to EBITDA	-19.88

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-91.87%
Operating Margin	-44.13%
Return on Assets TTM	-26.44%
Return on Equity TTM	-171.61%

Income Statement

Revenue TTM	$338,456,992
Revenue per Share TTM	$7.11
Quarterly Revenue Growth	81.30%
Gross Profit TTM	$308,289,984
EBITDA	$-244,623,008
Net Income to Common TTM	$-310,955,008
Diluted EPS TTM	$-6.58
Quarterly Earnings Growth YoY	81.27%

Balance Sheet

Total Cash MRQ	$327,340,992
Total Cash per Share MRQ	$6.76
Total Debt MRQ	$
Total Debt to Equity MRQ	207.00
Current Ratio MRQ	2.44
Book Value per Share MRQ	$1.92

Cash Flow

Operating Cash Flow TTM	$-132,570,000
Levered Free Cash Flow TTM	$-42,439,752

AXSM Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	48,462,400
Float Shares	36,118,040
Avg 10 Volume	1,117,810
Avg 30 Volume	None
Shares Short	6,619,135
Short Ratio	9.72
Short % of Shares	16.36%
% Held by Insiders	16.70%
% Held by Institutions	81.08%

Stock Price Summary

Beta	1.25
Fifty Two Week Low	$64.11
Fifty Two Week High	$105.00
Fifty Two Week Change	10.37%
Day 50 MA	$93.31
Day 200 MA	$85.29

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date